Crossmark

TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer

Crossref DOI link: https://doi.org/10.1186/s12885-019-5417-7

Published Online: 2019-03-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Caiyun

Yao, Hongyu

Liu, Huimin

Feng, Yanying

Yang, Zhijun http://orcid.org/0000-0002-2255-4034
Funding

Funding for this research was provided by:

Guangxi medical high-level backbone personnel training“139” Project (20141201 and 201822)

Guangxi Natural Science Foundation (2017GXNSFDA198009)

Special Fund of the 17th Guangxi New Century “Ten, Hundred, Thousand” Talent Project (2014210)

the National Natural Science Foundation of China (81360387)
License Information

Text and Data Mining valid from 2019-03-15
More Information

Article History

Received: 9 February 2018

Accepted: 27 February 2019

First Online: 15 March 2019

Ethics approval and consent to participate

: The use of patients’ tissues and data for the study had obtained written consents from all participates. The study was approved by The Ethics Committee of Affiliated tumor hospital of Guangxi Medical University with the following reference number: NO. LW2018001, and the research were conducted in conformity with the Declaration of Helsinki and the NIH guidelines (NIH Pub. No. 85–23, revised 1996) .

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.